
Novozymes A/S
CSE:NZYM B

Novozymes A/S
Revenue
Novozymes A/S
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
Novozymes A/S
CSE:NZYM B
|
Revenue
kr17.9B
|
CAGR 3-Years
9%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
P
|
Photocat A/S
STO:PCAT
|
Revenue
kr12.1m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
Novozymes A/S
Glance View
Novozymes A/S, a beacon of innovation in biotechnology, operates at the intricate intersection of science and sustainability. Born from the storied roots of Novo Nordisk in 2000, this Danish company has carved out a niche in the enzyme and microbial sector. Novozymes’ core competency lies in its ability to harness the power of natural organisms, using them to drive forward industrial solutions that are not only efficient but also eco-friendly. The company’s extensive portfolio of enzymes transforms processes across a diverse array of industries, including agriculture, food and beverages, household care, and bioenergy. By engineering microorganisms to optimize yield and reduce waste, Novozymes provides solutions that both enhance product performance and support environmental goals. Revenue generation for Novozymes predominantly stems from its ability to innovate and provide proprietary solutions that businesses around the world rely on to gain a competitive edge. While enzymes in detergents simplify stain removal and enable energy-efficient washing at lower temperatures, in agriculture, Novozymes' biological solutions enhance crop yield by fostering nutrient absorption and pest resilience. This vast spectrum of applications showcases the company's deep integration into its clients' production processes, creating a stable demand. Novozymes capitalizes on its research and development prowess, ensuring a continuous flow of advanced, tailor-made bio-solutions, thereby securing long-term partnerships and a sustainable revenue stream from its global market presence.

See Also
What is Novozymes A/S's Revenue?
Revenue
17.9B
DKK
Based on the financial report for Dec 31, 2023, Novozymes A/S's Revenue amounts to 17.9B DKK.
What is Novozymes A/S's Revenue growth rate?
Revenue CAGR 5Y
4%
Over the last year, the Revenue growth was 2%. The average annual Revenue growth rates for Novozymes A/S have been 9% over the past three years , 4% over the past five years .